Cancer Memoir as Counter-Archive: How Anne Boyer’s The Undying Rewrites the Politics of Illness

When Anne Boyer sat down to write about her breast cancer, she made a promise to herself that she would not tell the story the way she had been taught to tell it. The result, her Pulitzer Prize-winning memoir The Undying: Pain, Vulnerability, Mortality, Medicine, Art, Time, Dreams, Data, Exhaustion, Cancer, and Care, has now become the centerpiece of a new interdisciplinary study published in Frontiers in Sociology on 13 October 2026, which reads the memoir through the combined lenses of trauma neuroscience, feminist biopolitics, and global health policy. The research, conducted by Immaculate Catherine Anitha Christy and R. K. Jaishree Karthiga at Vellore Institute of Technology in Chennai, argues that Boyer’s fragmented, recursive prose is not merely a stylistic choice but a formal strategy that enacts the somatic violence of chemotherapy and the structural abandonment of working-class patients within late-capitalist biomedicine.

The study begins from a deceptively simple observation: contemporary illness narratives about breast cancer are dominated by a lexicon of heroism, feminine stoicism, and redemptive triumph. The brave fighter, the grateful survivor, and the transformed self are the figures through which cancer is culturally narrated across the United States. Boyer, who was working class and uninsured when she was diagnosed with triple-negative breast cancer, refuses all three. She explicitly states in the memoir that she does not want to tell the story of cancer in the way she has been taught to tell it. Instead, she foregrounds toxicity, institutional abandonment, and labor precarity, identifying the non-biological reasons that cancer causes suffering. The researchers argue that these conditions of oncological care are not incidental biographical circumstances but constitutive political realities that determine whether suffering is survivable, recognizable, and grievable.

To understand what Boyer’s prose is doing formally, the study draws on Bessel van der Kolk’s clinical account of implicit, non-declarative body memory from his 2014 book The Body Keeps the Score. Van der Kolk proposes that traumatic memories are not stored declaratively but in subcortical structures including the amygdala, hippocampus, and brain stem, and that trauma is remembered as impulses, autonomic dysregulations, and floods of affect rather than as narrative memory, bypassing the language center known as Broca’s area. The researchers are careful to stress that they use this framework not as a diagnostic claim about Boyer’s neurobiology but as a way of reading literary form. Boyer’s syntactically fragmented, temporally disjunctive, and affectively unsettled prose is read as a figuration of trauma’s resistance to verbal capture, a way the text can gesture toward the non-verbal register of somatic experience without constituting clinical evidence of subcortical encoding as such.

The clinical literature on cancer survivorship provides a separate but converging body of evidence. Amir and Ramati found in a matched control study that a higher proportion of long-term breast cancer patients had full and partial post-traumatic stress disorder than controls, with much worse physical and psychological quality of life. A recent systematic review found that depressive, anxious, and post-traumatic symptoms remain high among Asian American breast cancer survivors after treatment. Davidson and colleagues, in a scoping review of trauma-informed approaches to cancer care in Canada and the United States, showed that cancer patients often experience post-traumatic symptomatology in ways that mainstream cancer care does not address. This clinical gap is precisely what Boyer’s text dramatizes: the institution’s reduction of the patient’s complex traumatic experience to manageable data points. In one of the memoir’s most cited scenes, Boyer describes the repeated exhortations to rate her pain on a scale of one to ten, concluding that sensation is the enemy of quantification.

Boyer’s account of chemotherapy itself is among the most technically detailed in contemporary illness writing. She describes Adriamycin, whose generic name is doxorubicin, as a drug whose very name she likens to the brilliant and voluptuous red of a ruby, even as she notes its street names, the red devil and the red death. This conflation of poetic beauty and lethal danger enacts the general logic of chemotherapy: an imperative to treat balanced by the need for caution with drug toxicity. The body cannot distinguish between a cure and a poison; both are perceived as an attack. Boyer also traces the origin of the second drug she received, cyclophosphamide, to the chemical weapon developed under the name LOST, or mustard gas, which lives on only in chemotherapy. The researchers argue that this is not rhetorical flourish but the historical truth of the drugs injected into Boyer’s body, which contain the somatic memory of chemical warfare. Patients receiving chemotherapy face not only medically targeted violence but also sedimentary violence tied to a warlike past.

The phenomenon of chemotherapy-related cognitive impairment, colloquially known as chemobrain, is another site where Boyer’s autotheoretical methodology combines biomedical research with phenomenological testimony. She cites clinical images of patients on the same treatment showing significantly reduced activation of the left middle dorsolateral prefrontal cortex and premotor cortex. The blood-brain barrier excludes many chemotherapeutic agents, and it remains unclear how a drug administered peripherally would act within the central nervous system, a difficulty that makes the mechanism easier to dismiss as generalized cancer-related distress. Boyer treats this not as a settled matter of mechanism but as a lived reality. Patients with chemotherapy-related cognitive impairment, she writes, lose the ability to read, to recall words, to speak fluently, to picture themselves in the past, to tell their story, to know people they have known all their lives. The researchers read this as somatic testimony institutionally silenced when the patient’s embodied knowledge is deemed epistemically irrelevant by biomedical authority, reproducing the structure of precarity that Judith Butler identifies as constitutive of non-grievable subjectivity.

Butler’s analytics of precarity and grievability, developed in Precarious Life and Frames of War, provide the study’s political framework. Precarity names the differential exposure to vulnerability, the structurally uneven distribution of conditions of life and death along axes of gender, ethnicity, class, sexuality, and nationality. Grievability names the normatively authorized range of lives that can be publicly mourned. The researchers delineate a technical dynamic: precarity determines who materially suffers from insufficient care, epistemic injustice determines whose account of that insufficient care is believed, and the combination of both produces non-grievability, since a suffering that is both materially unaddressed and epistemically dismissed has no institutional mechanism for being recognized as what it is and mourned as such. Boyer’s working-class status as an uninsured patient is thus not incidental; it determines what care she receives, how she is treated in the clinical space, and whether her suffering warrants public mourning and political redress. Population-level evidence supports this reading. Wheeler and colleagues identified access to care, financial resources, and the quality of patient-provider interaction as potentially modifiable factors influencing whether a patient receives guideline-concordant treatment. Silber and colleagues found that socioeconomic status predicts differences in breast cancer survival even when the patient population is restricted to patients with Medicare and Medicaid.

The study also examines the pink-ribbon industrial complex of breast cancer culture, which Barbara Ehrenreich famously identified in 2001. This cultural apparatus requires that cancer patients perform a specific affective script of gratitude, positivity, and transformation that renders them legible as grievable subjects within dominant cultural economies of recognition. Boyer refuses this script explicitly. She describes the nurses giving her a glossy binder with a photo of a smiling silver-haired woman on its cover, titled Your Oncology Journey, of which she is certain the trip cannot be hers. Only those who survive, she notes, are admitted to the pinkwashed landscape of awareness in exchange for 5K runs, organic green smoothies, and positive thought. The researchers argue that this critique identifies exactly the normative frame Butler theorizes as grievability: a cultural imperative that cancer patients perform their suffering in ways that authorize, rather than challenge, the structural conditions that produce oncological precarity. The performance ignores what Boyer calls the industrial etiology of the disease and its unequal distribution by class.

The gendered organization of clinical labor is another central finding. Boyer recounts with rare specificity how women transmute bodies into data in the cancer pavilion, and how she herself is a patient made of information, produced by the work of women. The researchers read this as both a feminist critique of the healthcare system’s reproduction of patriarchal hierarchies of knowledge and authority and a phenomenological acknowledgment of the reduction of the patient to data by care. Boyer’s description of the pavilion as a cruel democracy of appearance, where all patients are reduced to a similar bald head and the same plastic chemotherapy port visible as a lump under the skin, is read as a form of institutional violence in which the person is reduced to a cluster of clinical signs rather than a subject inhabiting a world. Drawing on Kristeva’s concept of abjection, the researchers argue that Boyer’s refusal to contain the dissolution of bodily boundaries, including nosebleeds, nausea, and toxicity so extreme that patients are told to flush the toilet twice, is a political act that makes visible a form of bodily experience the pink-ribbon apparatus seeks to render invisible.

The researchers situate these literary-humanistic claims within a transnational epidemiological context. Each year, approximately 2.3 million people are diagnosed with breast cancer, and 670,000 die from it worldwide, according to the World Health Organization’s Global Breast Cancer Initiative. The most recent WHO survival data show that five-year survival estimates average 87.3 percent when health systems are well-resourced but fall to 41.9 percent in the lowest-income countries, with the lowest regional average in the WHO African Region at 39.1 percent. Gutnik and colleagues describe the differential breast cancer outcomes of African American and sub-Saharan African women as a tale of global inequities, while Unger-Saldaña traces similar disparities in low- and middle-income settings to challenges in early diagnosis and treatment. The study argues that the relationship between Boyer’s feminist micro-narratives and the WHO Global Breast Cancer Initiative and the United Nations Sustainable Development Goal 3 is one of productive tension: the WHO epidemiological understanding of the global burden of breast cancer lays the statistical foundation for Boyer’s individual experience to attain transnational importance, while what the scientific method does not generate is the phenomenologically rich story of what it is like, in the first-person singular, to inhabit a body traversing the structural conditions that produce statistical inequalities. Without humanistic frameworks that render visible the structural mechanisms by which gender, class, and ethnicity determine not only health outcomes but also the conditions of clinical encounter, institutional recognition, and epistemic authority, the equity imperatives of global health policy cannot be fully realized. Boyer’s memoir, the study concludes, stands as a feminist counter-archive that renders grievable what biopolitical regimes systematically exclude from the economies of institutional recognition and public mourning.

Subject of Research: Inscribed and expendable: oncological trauma, body memory, and the politics of grievability in Anne Boyer’s The Undying

Article Title: Inscribed and expendable: oncological trauma, body memory, and the politics of grievability in Anne Boyer’s The Undying

Article References: Christy, I. C. A., & Karthiga, R. K. J. (2026). Inscribed and expendable: oncological trauma, body memory, and the politics of grievability in Anne Boyer’s The Undying. Frontiers in Sociology, 11, Article 1916810. https://doi.org/10.3389/fsoc.2026.1916810

Image Credits: AI Generated

DOI: 10.3389/fsoc.2026.1916810

Keywords: Inscribed, expendable, oncological, trauma, body, memory, politics, grievability, Anne, Boyer, Undying, scientific research